Vitamin D deficiency and impaired placental function: potential regulation by glucocorticoids?

Reproduction. 2017 May;153(5):R163-R171. doi: 10.1530/REP-16-0647. Epub 2017 Jan 30.

Abstract

Maternal vitamin D deficiency has been implicated in a range of pregnancy complications including preeclampsia, preterm birth and intrauterine growth restriction. Some of these adverse outcomes arise from alterations in placental function. Indeed, vitamin D appears critical for implantation, inflammation, immune function and angiogenesis in the placenta. Despite these associations, absence of the placental vitamin D receptor in mice provokes little effect. Thus, interactions between maternal and fetal compartments are likely crucial for instigating adverse placental changes. Indeed, maternal vitamin D deficiency elicits changes in glucocorticoid-related parameters in pregnancy, which increase placental and fetal glucocorticoid exposure. As in utero glucocorticoid excess has a well-established role in eliciting placental dysfunction and fetal growth restriction, this review proposes that glucocorticoids are an important consideration when understanding the impact of vitamin D deficiency on placental function and fetal development.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Fetal Growth Retardation / etiology*
  • Glucocorticoids / adverse effects*
  • Humans
  • Mice
  • Placenta / drug effects
  • Placenta / physiopathology*
  • Pregnancy
  • Vitamin D Deficiency / complications*

Substances

  • Glucocorticoids